Kuros Biosciences Ltd.
Develops biologic technologies for tissue repair and bone regeneration.
KURN | SW
Overview
Corporate Details
- ISIN(s):
- CH0325814116
- LEI:
- 5299006U5POB2AVTT709
- Country:
- Switzerland
- Address:
- Wagisstraße 25, 8952 Schlieren
- Website:
- https://kurosbio.com/
- Sector:
- Manufacturing
Description
Kuros Biosciences is a life sciences company that discovers, develops, and delivers innovative biologic technologies focused on tissue repair and bone regeneration. The company's mission is to address unmet clinical needs for safer, faster, and more predictable bone healing. Its primary commercial product is MagnetOs, an advanced bone graft designed to enhance bone formation. The efficacy of MagnetOs is supported by a comprehensive global research program, "Project Fusion," which includes scientific, pre-clinical, and Level I human clinical studies. Kuros Biosciences serves surgeons and patients across multiple medical fields, including spine, extremities, trauma, and oncology, leveraging deep scientific expertise and collaboration with leading clinical experts.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2016-06-28 07:00 |
Kuros Biosciences AG: valuationLAB Initiates Research Coverage on Kuros
|
English | 10.3 KB | ||
| 2016-06-23 18:31 |
First Trading Day of New Kuros Share after Reverse Split
|
English | 6.5 KB | ||
| 2016-06-16 14:38 |
Kuros Bioscience's Shareholders Approve All Resolutions
|
English | 6.5 KB | ||
| 2016-05-26 07:00 |
Kuros Biosciences Invites to the Annual Shareholders' Meeting 2016
|
English | 8.0 KB | ||
| 2016-04-26 07:00 |
Kuros Biosciences Reports Financial Results for 2015
|
English | 18.6 KB | ||
| 2016-04-20 07:00 |
Kuros receives milestone payment from Checkmate
|
English | 8.4 KB | ||
| 2016-03-08 07:00 |
Kuros Biosciences Ltd. appoints Chief Medical Officer
|
English | 6.7 KB | ||
| 2016-01-20 07:00 |
Kuros Biosurgery Holding Ltd. closes merger with Cytos Biotechnology Ltd. which…
|
English | 10.1 KB | ||
| 2016-01-08 07:00 |
Cytos Biotechnology Ltd. will be renamed Kuros Biosciences Ltd., constitutes it…
|
English | 7.0 KB | ||
| 2016-01-06 12:05 |
Cytos Biotechnology AG: Extraordinary Shareholders' Meeting approves all resolu…
|
English | 6.5 KB | ||
| 2015-12-15 07:00 |
Cytos Biotechnology Ltd. invites for an Extraordinary Shareholders' Meeting
|
English | 6.5 KB | ||
| 2015-12-03 07:00 |
Cytos Biotechnology and Kuros Biosurgery to combine to create Kuros Biosciences
|
English | 16.3 KB | ||
| 2015-08-12 07:00 |
Cytos Biotechnology Ltd exclusively licenses its VLP platform for the treatment…
|
English | 7.4 KB | ||
| 2015-07-29 17:30 |
Cytos Biotechnology Ltd Reports the Financial Results of the First Half Year 20…
|
English | 12.5 KB | ||
| 2015-06-29 14:38 |
Annual Shareholders' Meeting of Cytos Biotechnology Ltd: Shareholders approve a…
|
English | 5.9 KB |
Automate Your Workflow. Get a real-time feed of all Kuros Biosciences Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Kuros Biosciences Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Kuros Biosciences Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-23 | N/A | Executive member | Sell | None | 1,264,800.00 CHF |
| 2025-04-17 | N/A | Executive member | Sell | None | 13,344.49 CHF |
| 2025-03-18 | N/A | Non-Executive member | Buy | None | 38,200.00 CHF |
| 2024-12-11 | N/A | Executive member | Sell | None | 4,702,500.00 CHF |
| 2024-11-15 | N/A | Non-Executive member | Buy | None | 925,210.00 CHF |
| 2024-11-14 | N/A | Non-Executive member | Sell | None | 592,000.00 CHF |
| 2024-11-12 | N/A | Executive member | Sell | None | 13,890.86 CHF |
| 2024-09-25 | N/A | Executive member | Sell | None | 8,226,000.00 CHF |
| 2024-09-25 | N/A | Non-Executive member | Sell | None | 3,656,000.00 CHF |
| 2024-09-24 | N/A | Non-Executive member | Buy | None | 223,720.00 CHF |
Peer Companies
